BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Hemophilia Alliance - ECPv6.3.7//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://hemoalliance.org
X-WR-CALDESC:Events for Hemophilia Alliance
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250722T130000
DTEND;TZID=America/New_York:20250722T140000
DTSTAMP:20260501T210130
CREATED:20250707T164147Z
LAST-MODIFIED:20250708T150629Z
UID:71108-1753189200-1753192800@hemoalliance.org
SUMMARY:🟥 Member Webinar : Hemophilia Alliance Hosts - A webinar from Octapharma - Review The Clinical Benefits of wilate®\, Highlighting The Benefits vs Current vWD Therapies
DESCRIPTION:Date: Tuesday\, July 22nd\, 2025\nTime: 1:00pm – 2:00pm ET \n  \n \n  \n  \n  \n \nWEBINAR TOPIC: \nReview the clinical benefits of wilate®\, highlighting the benefits vs current vWD therapies. \nOBJECTIVES: \n\nUnderstand the attributes of wilate® for vWD: 1:1 ratio which mimics the physiologic activity of vWF and FVIII and the synchronous decay curves\, which facilitates factor activity monitoring.\nUnderstand the absence of vWF or FVIII accumulation when using wilate® during surgery and prophylaxis.\nReview the only product approved for children older than 6 years and adults with any type of vWD and under any clinical circumstance.\n\nAUDIENCE: \nAll HTC Staff \nSPEAKER: \nClaudio Sandoval\, Senior Director of Scientific & Medical Affairs at Octapharma \nClaudio Sandoval is the Senior Director of Scientific & Medical Affairs at Octapharma. Before his current role he was a pediatric hematologist-oncologist for 30 years caring for children with bleeding disorders\, cancer\, sickle cell disease\, and other maladies. Claudio graduated from New York Medical College and trained at Schneider Children’s Hospital in New Hyde Park\, NY and St. Jude Children’s Research Hospital in Memphis\, TN.
URL:https://hemoalliance.org/alliance-events/a-webinar-from-octapharma-review-the-clinical-benefits-of-wilate-highlighting-the-benefits-vs-current-vwd-therapies/
CATEGORIES:Members Only,Webinar
ATTACH;FMTTYPE=image/png:https://hemoalliance.org/wp-content/uploads/2024/06/Octapharma-logo-blue.png
END:VEVENT
END:VCALENDAR